| scholarly article | Q13442814 |
| P2093 | author name string | Prummel MF | |
| Endert E | |||
| Roos CM | |||
| Oosting H | |||
| Pouw EM | |||
| P2860 | cites work | Purpura and dermal thinning associated with high dose inhaled corticosteroids | Q34652477 |
| The course of biochemical parameters of bone turnover during treatment with corticosteroids | Q68190611 | ||
| Osteocalcin in human serum: a circadian rhythm | Q69865344 | ||
| Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis | Q72580014 | ||
| P433 | issue | 6777 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteocalcin | Q59250722 |
| P1104 | number of pages | 2 | |
| P304 | page(s) | 627-628 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Beclomethasone inhalation decreases serum osteocalcin concentrations | |
| P478 | volume | 302 |
| Q71955645 | A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease |
| Q43629981 | A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in childhood asthma |
| Q72524739 | Adverse effects of inhaled corticosteroids |
| Q35258478 | Anti-inflammatory drugs in the treatment of allergic disease |
| Q50892754 | Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: a prospective study for 18 months. |
| Q34458603 | Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing |
| Q43164954 | Beclomethasone and osteocalcin |
| Q33909166 | Beclomethasone for asthma in children: effects on linear growth |
| Q36262991 | Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids |
| Q50863765 | Bone mineral density and body composition in patients with airflow obstruction--the role of inhaled steroid therapy, disease and lifestyle. |
| Q50910918 | Bone mineral density and bone metabolism of prepubertal children with asthma after long-term treatment with inhaled corticosteroids. |
| Q28325560 | Bone-alkaline phosphatase as indicator of bone formation |
| Q33588402 | Comparative review of the effects of inhaled beclomethasone dipropionate and budesonide on bone |
| Q35823544 | Corticosteroid induced osteoporosis in severe menstrual asthma. Steroid sparing drugs may be useful |
| Q41241542 | Corticosteroid-induced bone loss. Prevention and management |
| Q35563153 | Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma |
| Q71586494 | Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids |
| Q71402647 | Effect of inhaled beclomethasone on serum markers of collagen metabolism in postmenopausal asthmatic women |
| Q35533770 | Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects |
| Q36287161 | Effect of orally administered beclomethasone dipropionate on calcium absorption from the gut in normal subjects |
| Q72168671 | Effect of prolonged use of inhaled steroids on the cellular immunity of children with asthma |
| Q41752122 | Effects of inhaled corticosteroids on bone density and metabolism |
| Q36571329 | Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group |
| Q41728966 | Efficacy and safety of inhaled corticosteroids. New developments |
| Q86716933 | Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly |
| Q43671243 | Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma |
| Q48192371 | Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma |
| Q35158568 | Fracture prevention in COPD patients; a clinical 5-step approach |
| Q34798713 | How much coughing is normal? |
| Q42659511 | Improved safety with equivalent asthma control in adults with chronic severe asthma on high-dose fluticasone propionate |
| Q73953465 | Influence of inhaled corticosteroids and dietary intake on bone density and metabolism in patients with moderate to severe asthma |
| Q51649420 | Inhaled and Nasal Corticosteroid Use and the Risk of Fracture |
| Q33851527 | Inhaled and nasal corticosteroids: safety aspects |
| Q40832408 | Inhaled corticosteroids in children. Is there a 'safe' dosage? |
| Q43536167 | Inhaled corticosteroids, bone formation, and osteocalcin |
| Q35852768 | Inhaled corticosteroids, bone mineral density and fracture in older people |
| Q70726875 | Inhaled corticosteroids--effect on bone? |
| Q68007234 | Inhaled corticosteroids: benefits and risks |
| Q78093238 | Lipid and protein metabolism in asthma. Effects of diet and corticosteroid therapy |
| Q41611539 | Management of complications of glucocorticoid therapy |
| Q40909504 | Methods of measurement of bone turnover and clinical evaluation of osteoporosis: relevance to asthma and corticosteroid therapy |
| Q34798671 | Osteocalcin, growth, and inhaled corticosteroids: a prospective study |
| Q34342546 | Osteoporosis in childhood: bone density of children in health and disease |
| Q40861599 | Pharmacokinetic optimisation of inhaled steroid therapy in asthma |
| Q35277314 | Recent advances in asthma |
| Q38248458 | Safety considerations of inhaled corticosteroids in the elderly. |
| Q70726872 | Safety of high-dose inhaled corticosteroids |
| Q38839524 | Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. |
| Q33543492 | Steroid-induced osteoporosis. Are your asthmatic patients at risk? |
| Q36728422 | Systemic activity of inhaled and swallowed beclomethasone dipropionate and the effect of different inhaler devices |
| Q36287490 | Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects |
| Q72645364 | Systemic effects of inhaled corticosteroids |
| Q72379686 | Testosterone levels during systemic and inhaled corticosteroid therapy |
| Q57072321 | The Childhood Asthma Management Program (CAMP) |
| Q48098899 | Therapeutic controversies in the treatment of asthma |
| Q35041015 | Treatment of allergic asthma |
| Q41670357 | Treatment with corticosteroids |
| Q40429087 | [Exogenous Cushing's syndrome and glucocorticoid withdrawal]. |
Search more.